268 related articles for article (PubMed ID: 14695333)
1. Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study.
Alonso SR; Ortiz P; Pollán M; Pérez-Gómez B; Sánchez L; Acuña MJ; Pajares R; Martínez-Tello FJ; Hortelano CM; Piris MA; Rodríguez-Peralto JL
Am J Pathol; 2004 Jan; 164(1):193-203. PubMed ID: 14695333
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of cell cycle regulators Cyclin D1, p14, p16, CDK4 and Rb in nodular melanomas.
Bachmann IM; Straume O; Akslen LA
Int J Oncol; 2004 Dec; 25(6):1559-65. PubMed ID: 15547691
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling of primary cutaneous melanoma.
Winnepenninckx V; Van den Oord JJ
Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
[TBL] [Abstract][Full Text] [Related]
5. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
[TBL] [Abstract][Full Text] [Related]
6. Thin Melanoma: A Generic Term Including Four Histological Subtypes of Cutaneous Melanoma.
Roncati L; Pusiol T; Piscioli F
Acta Dermatovenerol Croat; 2016 Dec; 24(4):169-174. PubMed ID: 28128089
[TBL] [Abstract][Full Text] [Related]
7. Malignant melanotic schwannian tumor: a clinicopathologic, immunohistochemical, and gene expression profiling study of 40 cases, with a proposal for the reclassification of "melanotic schwannoma".
Torres-Mora J; Dry S; Li X; Binder S; Amin M; Folpe AL
Am J Surg Pathol; 2014 Jan; 38(1):94-105. PubMed ID: 24145644
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of markers of the metabolic phenotype in human cutaneous melanoma.
Nájera L; Alonso-Juarranz M; Garrido M; Ballestín C; Moya L; Martínez-Díaz M; Carrillo R; Juarranz A; Rojo F; Cuezva JM; Rodríguez-Peralto JL
Br J Dermatol; 2019 Jul; 181(1):114-127. PubMed ID: 30537064
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of thymidylate synthase (TS) expression in cutaneous malignant melanoma.
Shimizu A; Kaira K; Yasuda M; Asao T; Ishikawa O
Neoplasma; 2016; 63(2):282-7. PubMed ID: 26774151
[TBL] [Abstract][Full Text] [Related]
10. Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma.
Mihic-Probst D; Kuster A; Kilgus S; Bode-Lesniewska B; Ingold-Heppner B; Leung C; Storz M; Seifert B; Marino S; Schraml P; Dummer R; Moch H
Int J Cancer; 2007 Oct; 121(8):1764-70. PubMed ID: 17597110
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation.
Albino AP; Juan G; Traganos F; Reinhart L; Connolly J; Rose DP; Darzynkiewicz Z
Cancer Res; 2000 Aug; 60(15):4139-45. PubMed ID: 10945621
[TBL] [Abstract][Full Text] [Related]
12. PUMA expression is significantly reduced in human cutaneous melanomas.
Karst AM; Dai DL; Martinka M; Li G
Oncogene; 2005 Feb; 24(6):1111-6. PubMed ID: 15690057
[TBL] [Abstract][Full Text] [Related]
13. Proteins involved in pRb and p53 pathways are differentially expressed in thin and thick superficial spreading melanomas.
de Sá BC; Fugimori ML; Ribeiro Kde C; Duprat Neto JP; Neves RI; Landman G
Melanoma Res; 2009 Jun; 19(3):135-41. PubMed ID: 19369901
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.
Donizy P; Zietek M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
Diagn Pathol; 2015 Jul; 10():86. PubMed ID: 26134500
[TBL] [Abstract][Full Text] [Related]
15. Reduced expression of p16 and p27 is correlated with tumour progression in cutaneous melanoma.
Sanki A; Li W; Colman M; Karim RZ; Thompson JF; Scolyer RA
Pathology; 2007 Dec; 39(6):551-7. PubMed ID: 18027257
[TBL] [Abstract][Full Text] [Related]
16. p16 expression in primary malignant melanoma is associated with prognosis and lymph node status.
Mihic-Probst D; Mnich CD; Oberholzer PA; Seifert B; Sasse B; Moch H; Dummer R
Int J Cancer; 2006 May; 118(9):2262-8. PubMed ID: 16331607
[TBL] [Abstract][Full Text] [Related]
17. Novel biomarkers in malignant melanoma.
Bosserhoff AK
Clin Chim Acta; 2006 May; 367(1-2):28-35. PubMed ID: 16480699
[TBL] [Abstract][Full Text] [Related]
18. Correlation of histopathologic characteristics to protein expression and function in malignant melanoma.
Welinder C; Pawłowski K; Szasz AM; Yakovleva M; Sugihara Y; Malm J; Jönsson G; Ingvar C; Lundgren L; Baldetorp B; Olsson H; Rezeli M; Laurell T; Wieslander E; Marko-Varga G
PLoS One; 2017; 12(4):e0176167. PubMed ID: 28445515
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of sex determining region Y-box 11 (SOX11) in cutaneous malignant melanoma.
Jian J; Guoying W; Jing Z
J Int Med Res; 2013 Aug; 41(4):1221-7. PubMed ID: 23867449
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of cell cycle modulators p21, p27, p53, Rb and proapoptotic Bcl-2-related proteins Bax and Bak in cutaneous melanoma is associated with worse patient prognosis: preliminary findings.
Tchernev G; Orfanos CE
J Cutan Pathol; 2007 Mar; 34(3):247-56. PubMed ID: 17302609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
